PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate
October 29, 2026
October 29, 2026
HONG KONG, Oct. 29 -- The Hong Kong Polytechnic University issued the following news release:
* * *
PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate
*
Researchers at The Hong Kong Polytechnic University (PolyU) have successfully developed an innovative imaging biomarker, the Tumour Heterogeneity Index (THI), which enables non-invasive assessm . . .
* * *
PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate
*
Researchers at The Hong Kong Polytechnic University (PolyU) have successfully developed an innovative imaging biomarker, the Tumour Heterogeneity Index (THI), which enables non-invasive assessm . . .
